Amiloride Clinical Trial In Optic Neuritis (ACTION) protocol: a randomised, double blind, placebo controlled trial

INTRODUCTION: Neurodegeneration is a widely accepted contributor to the development of long-term disability in multiple sclerosis (MS). While current therapies in MS predominantly target inflammation and reduce relapse rate they have been less effective at preventing long-term disability. The identi...

Descripción completa

Detalles Bibliográficos
Autores principales: McKee, Justin B, Elston, John, Evangelou, Nikos, Gerry, Stephen, Fugger, Lars, Kennard, Christopher, Kong, Yazhuo, Palace, Jacqueline, Craner, Matthew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4654308/
https://www.ncbi.nlm.nih.gov/pubmed/26553836
http://dx.doi.org/10.1136/bmjopen-2015-009200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4654308/
https://www.ncbi.nlm.nih.gov/pubmed/26553836
http://dx.doi.org/10.1136/bmjopen-2015-009200

Ejemplares similares